Charnwood Molecular will be able to grow its teams and add drug discovery service lines at the modernised facility
Loughborough’s life sciences hub Charnwood Campus has recommissioned its synthetic and chemistry research facility to cater to its newest occupier, pre-clinical discovery contract research organisation (CRO) Charnwood Molecular.
The three-storey facility has been modernised by engineering firm Couch Perry Wilkes, following the delivery of several projects on the campus including 33,000 sqft of laboratory space for the UK Department of Health and Social Care’s Lighthouse Lab.
Part-funded (£3.5m) by the Enterprise Zone reinvestment fund facilitated through co-operation with the Leicester and Leicestershire Enterprise Partnership (LLEP) and Charnwood Borough Council (CBC), the laboratories will provide capacity for future growth and expansion of Charnwood Molecular’s teams while facilitating the addition of drug discovery service lines.
Charnwood Campus Commercial Director Gosia Khrais says: “It is a great pleasure to welcome Charnwood Molecular as a new occupier here. The project is a recommissioning of an existing facility to meet the bespoke requirements of this fantastic CRO, and includes construction of a car park with EV charging points.”
Carl Hubbard, Associate Director at Couch Perry Wilkes said: “It is a privilege to be involved in such a prestigious project to bring a state-of-the-art building back to life to support the development and growth of its ambitious new occupier, following Couch Perry Wilkes’ previous successful delivery of the Lighthouse Lab facility at Charnwood Campus. The works have extended the life and improved the building’s efficiencies and provide Charnwood Molecular with a future-proof base in which expand its team and service lines.”
Charnwood Campus is part of the Loughborough and Leicester Science and Innovation Enterprise Zone, which covers close to 290 hectares of development land across four individual locations, focusing on science and innovation. The campus is home to blue-chip organisations including Almac, 3M and Kindeva.